2009-05-29 |
rTMS-stroke-phase I |
CIREN |
Registered |
2009-03-13 |
Clinical evaluation of the effect anti-inflammatory of the extract of Mangifera indica L. (Vimang®) in patients with diagnosis of Bronchial Asthma |
CQF |
Registered |
2009-02-11 |
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
CIGB |
Registered |
2009-02-11 |
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. |
CIGB |
Registered |
2008-09-12 |
Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain. |
FINLAY |
Registered |
2010-12-17 |
Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors. |
CIM |
Registered |
2010-12-17 |
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. |
CIM |
Registered |
2010-12-17 |
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II |
CIM |
Registered |
2010-12-17 |
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II |
CIM |
Registered |
2009-02-11 |
Recombinant interferon alpha-2b in paranoid schizophrenia. |
CIGB |
Registered |
2010-12-28 |
InCarbacel-II |
CIGB |
Registered |
2008-10-16 |
FASECU I |
CIGB |
Registered |
2008-09-18 |
Tisuacryl® in Dental Hyperesthesia |
BIOMAT |
Registered |
2010-12-27 |
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed |
CIGB |
Registered |
2010-12-24 |
CIGB-128 administration to patients with surgically-treated keloids. |
CIGB |
Registered |
2010-12-24 |
Application of CIGB-128 in keloid patients undergoing surgical exeresis. |
CIGB |
Registered |
2009-02-26 |
CITOPROT-III |
CIGB |
Registered |
2008-07-29 |
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine. |
FINLAY |
Registered |
2008-07-29 |
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET. |
FINLAY |
Registered |
2010-12-17 |
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I. |
CIM |
Registered |